Lantus Injection, Solution
Product Images NDC 50090-0876

35 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Lantus (NDC 50090-0876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lantus 01)

Figure 1 (Lantus 01)
Chemical structure diagram of insulin glargine showing its two polypeptide chains, A and B. The amino acid sequence is detailed with covalent disulfide bonds indicated between cysteine residues connecting the chains, illustrating the molecular structure of this active ingredient.*
FDA Label Image

Figure (Lantus 02)

Figure (Lantus 02)
A line graph comparing glucose infusion rates (mg/kg/min) over time (hours) after subcutaneous injection for insulin glargine and NPH insulin. The solid line represents insulin glargine, showing a gradual, sustained rate, while the dashed line represents NPH insulin, peaking earlier and declining faster. Observation period ends are marked by triangles on the time axis.*
FDA Label Image

Figure (Lantus 03)

Figure (Lantus 03)
An instructional illustration showing hands removing a cap from a vial, likely demonstrating preparation steps for the injection solution. The image is related to subcutaneous administration of medication, consistent with insulin glargine injection.*
FDA Label Image

Figure (Lantus 04)

Figure (Lantus 04)
An instructional black-and-white line drawing showing hands peeling off a protective seal from the top of a vial. This depicts the step of removing the seal before using the vial, relevant for injectable medications like Lantus insulin glargine 100 units/mL solution for subcutaneous injection.*
FDA Label Image

Figure (Lantus 05)

Figure (Lantus 05)
An instructional illustration showing two hands preparing an injection syringe. One hand holds the syringe barrel while the other hand is pulling the plunger to draw liquid into the syringe. This image likely depicts the preparation step for a subcutaneous injection of a medication such as insulin glargine.*
FDA Label Image

Figure (Lantus 06)

Figure (Lantus 06)
A black-and-white instructional illustration showing a hand holding a syringe and a vial. The syringe needle is inserted into the vial's rubber stopper, with an arrow indicating the action to pull or draw medication into the syringe. This image likely demonstrates drawing insulin glargine solution from a vial for injection.*
FDA Label Image

Figure (Lantus 07)

Figure (Lantus 07)
An instructional line drawing showing a hand holding a syringe with the thumb pressing the plunger, illustrating the method to inject or expel medication from the syringe. An arrow indicates the thumb movement downward on the plunger.*
FDA Label Image

Figure (Lantus 08)

Figure (Lantus 08)
An instructional illustration showing a hand holding a syringe with a needle attached, and the other hand manipulating the syringe plunger. The arrow indicates the direction of plunger movement, suggesting the action of drawing or pushing liquid during preparation or injection.*
FDA Label Image

Figure (Lantus 09)

Figure (Lantus 09)
Instructional illustration showing a person's hand inserting a needle or similar device into a vial or container held by the other hand, likely demonstrating a preparation or injection technique related to the Lantus insulin glargine injection.*
FDA Label Image

Figure (Lantus 10)

Figure (Lantus 10)
An instructional illustration showing a hand holding a syringe and a vial, demonstrating the technique for drawing insulin glargine solution for subcutaneous injection, associated with Lantus 100 IU/mL injection by A-S Medication Solutions.*
FDA Label Image

Figure (Lantus 11)

Figure (Lantus 11)
An instructional diagram showing the components of the Lantus SoloStar insulin glargine injection pen. It details the pen cap, pen needle assembly with protective seal, and pen body including the insulin reservoir, rubber seal, dose window, dosage selector, and injection button.*
FDA Label Image

Figure (Lantus 12)

Figure (Lantus 12)
An instructional illustration showing hands preparing a prefilled injection pen for subcutaneous administration. The image details removal of a cap from the injection pen containing insulin glargine solution. It visually demonstrates the initial steps for using a Lantus 100 units/mL injection pen by A-S Medication Solutions.*
FDA Label Image

Figure (Lantus 13)

Figure (Lantus 13)
An instructional illustration showing hands handling a prefilled syringe of Lantus (insulin glargine) injection solution 100 IU/mL, with a red 'X' over the image suggesting an incorrect technique or action.*
FDA Label Image

Figure (Lantus 14)

Figure (Lantus 14)
An instructional diagram showing a hand holding a Lantus insulin glargine injection pen, demonstrating the step to rotate the dial or cap, indicated by a red upward arrow. This illustrates part of the preparation or dose-setting process for the subcutaneous injection solution.*
FDA Label Image

Figure (Lantus 15)

Figure (Lantus 15)
An instructional illustration showing a subcutaneous injection pen assembly process for Lantus insulin glargine 100 units/mL. The image depicts a pen needle being separated into two parts labeled 'Keep' and 'Discard,' with arrows indicating the direction to pull apart the components before attaching to the injection pen.*
FDA Label Image

Figure (Lantus 16)

Figure (Lantus 16)
An instructional illustration showing a hand preparing a syringe labeled with measurement markings, with an inset zoom focusing on the syringe tip cap being removed. The diagram highlights the step for removing the cap before use.*
FDA Label Image

Figure (Lantus 17)

Figure (Lantus 17)
An instructional diagram showing the adjustment of the dose on an insulin pen. The image depicts a hand turning the dose selector dial, with numbers indicating dose units visible on the pen display, and a red arrow illustrating the direction to turn for dose increase.*
FDA Label Image

Figure (Lantus 18)

Figure (Lantus 18)
An instructional illustration showing a hand holding a syringe filled with medication. The syringe is positioned for a subcutaneous injection, indicated by a red arrow pointing to the left, suggesting the direction of injection.*
FDA Label Image

Figure (Lantus 19)

Figure (Lantus 19)
An illustration showing a hand holding an injection pen, with an arrow indicating to push the plunger and a symbol indicating to wait 10 seconds after injection. The image demonstrates the proper technique for administering a subcutaneous injection using the pen device.*
FDA Label Image

Figure (Lantus 20)

Figure (Lantus 20)
An instructional illustration showing a close-up of a hand holding a Lantus insulin pen and another hand handling a small needle cap or component. The image likely depicts steps related to preparing or attaching the needle for subcutaneous injection of Lantus insulin glargine solution.*
FDA Label Image

Figure (Lantus 21)

Figure (Lantus 21)
An instructional illustration showing a hand removing the cap from a container while another hand holds a syringe with the needle pointing downward. A blue arrow indicates the action of removing the cap from the container.*
FDA Label Image

Figure (Lantus 22)

Figure (Lantus 22)
An instructional illustration showing a person's hands holding an insulin pen. The image zooms in on the dose selector window, highlighting the dial adjustment and indicating a partial turn of the dose knob to change the selected insulin glargine dose on the pen.*
FDA Label Image

Figure (Lantus 23)

Figure (Lantus 23)
Instructional diagram showing the preparation of an injection with a syringe. The illustration highlights holding the syringe upright and expelling air by pressing the plunger to create a small spray from the needle tip.*
FDA Label Image

Figure (Lantus 24)

Figure (Lantus 24)
Lantus Solostar 100 units/mL insulin glargine injection pen for subcutaneous use. The image shows a prefilled pen device with a dose selector at the end, a needle cap, and a label indicating the product name 'Lantus Solostar' and strength '100 units/mL' by A-S Medication Solutions. The pen is designed for human prescription drug use.*
FDA Label Image

Figure (Lantus 25)

Figure (Lantus 25)
An instructional diagram showing how to adjust the dose on a Lantus insulin glargine 100 units/mL injection pen by rotating the dose selector dial at the end of the pen. Fingers are holding and turning the dial indicated by a curved arrow.*
FDA Label Image

Figure (Lantus 26)

Figure (Lantus 26)
An illustration showing a close-up of a dial on a device, displaying the selection of 20 units. The dial is likely part of an injection device used for dosing medication such as insulin.*
FDA Label Image

Figure (Lantus 27)

Figure (Lantus 27)
An illustration showing a close-up of a dosing selector on an injection pen dialed to 20 units, with the text '21 units selected' below the image. The image highlights setting the dose for a subcutaneous injection, related to Lantus insulin glargine injection, solution 100 units/mL.*
FDA Label Image

Figure (Lantus 28)

Figure (Lantus 28)
An instructional illustration showing a hand holding a Lantus insulin glargine injection pen, with an arrow indicating the direction to pull or remove the needle cap. The pen displays a dosage dial and measurement markings on the syringe barrel.*
FDA Label Image

Figure (Lantus 29)

Figure (Lantus 29)
Instructional illustration demonstrating the correct hand positioning and method for turning the dose dial on a Lantus insulin glargine injection pen, with magnified insets showing the proper way to grip and rotate the gray dose knob, and a warning against incorrect thumb placement.*
FDA Label Image

Figure (Lantus 30)

Figure (Lantus 30)
An instructional illustration showing a hand holding a Lantus insulin glargine 100 units/mL injection pen. The image highlights twisting the dial on the injection pen for 10 seconds, indicating the step needed to prepare the dose before subcutaneous injection.*
FDA Label Image

Figure (Lantus 31)

Figure (Lantus 31)
An instructional diagram showing hands holding a Lantus (insulin glargine) 100 units/mL injection pen. The image illustrates the step of attaching the needle cap to the pen, indicated by a blue arrow pointing to the connection point. The pen's dosage window and dosage scale are partially visible.*
FDA Label Image

Figure (Lantus 32)

Figure (Lantus 32)
An instructional illustration showing hands preparing a Lantus injection pen. The image depicts removing a protective cap by twisting and pulling, with arrows indicating the direction of movement to ready the injection pen for use.*
FDA Label Image

Figure (Lantus 33)

Figure (Lantus 33)
An instructional illustration showing hands removing the cap from a small vial and a container, with an arrow indicating the next step to open or mix the contents. This image likely relates to preparing or handling a medication vial for injection use.*
FDA Label Image

Figure (Lantus 34)

Figure (Lantus 34)
An instructional illustration showing two hands holding a Lantus insulin glargine injection pen. The left hand holds the pen while the right hand pulls off the pen cap, indicated by a blue arrow pointing away from the pen. The image demonstrates the initial step of preparing the pen for subcutaneous injection.*
FDA Label Image

Label Image (Lbl500900876)

Label Image (Lbl500900876)
Lantus insulin glargine injection, solution, 100 units/mL, by A-S Medication Solutions. The label indicates a product NDC of 50090-0876-0 and states each vial contains 100 units insulin glargine in a 10 mL vial. Storage instructions specify refrigeration at 36 to 46 degrees Fahrenheit and caution against freezing. The label advises discarding after 10 doses and describes the vial as a multiple-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.